Atlas Trials

Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)

Clinical trial NCT04391101 · UNKNOWN

Trial details

NCT number
NCT04391101
Sponsor
Hospital San Vicente Fundación
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
SARS-Cov-2
Start date
2020-06-01
Primary completion
2021-06-01
Enrollment
231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.